• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

NARASIMHA: Novel Assay based on Targeted RNA Sequencing to Identify ChiMeric Gene Fusions in Hematological Malignancies.

作者信息

Patkar Nikhil, Bhanshe Prasanna, Rajpal Sweta, Joshi Swapnali, Chaudhary Shruti, Chatterjee Gaurav, Tembhare Prashant, Dhamne Chetan, Prasad Maya, Moulik Nirmalya Roy, Shetty Dhanalaxmi, Gokarn Anant, Bonda Avinash, Nayak Lingaraj, Punatkar Sachin, Bagal Bhausaheb, Sengar Manju, Narula Gaurav, Khattry Navin, Banavali Shripad, Subramanian P G, Gujral Sumeet

机构信息

Haematopathology Laboratory, ACTREC, Tata Memorial Centre, Navi Mumbai, India.

Homi Bhabha National Institute (HBNI), Mumbai, India.

出版信息

Blood Cancer J. 2020 May 5;10(5):50. doi: 10.1038/s41408-020-0313-6.

DOI:10.1038/s41408-020-0313-6
PMID:32372024
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7200652/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e120/7200652/4d0b8d648028/41408_2020_313_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e120/7200652/4d0b8d648028/41408_2020_313_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e120/7200652/4d0b8d648028/41408_2020_313_Fig1_HTML.jpg

相似文献

1
NARASIMHA: Novel Assay based on Targeted RNA Sequencing to Identify ChiMeric Gene Fusions in Hematological Malignancies.纳拉辛哈：基于靶向RNA测序的新型检测方法，用于鉴定血液系统恶性肿瘤中的嵌合基因融合。
Blood Cancer J. 2020 May 5;10(5):50. doi: 10.1038/s41408-020-0313-6.
2
Detection of leukemia gene fusions by targeted RNA-sequencing in routine diagnostics.通过靶向 RNA 测序在常规诊断中检测白血病基因融合。
BMC Med Genomics. 2020 Jul 29;13(1):106. doi: 10.1186/s12920-020-00739-4.
3
Clinical Validation of FusionPlex RNA Sequencing and Its Utility in the Diagnosis and Classification of Hematologic Neoplasms.FusionPlex RNA测序的临床验证及其在血液肿瘤诊断和分类中的应用
J Mol Diagn. 2023 Dec;25(12):932-944. doi: 10.1016/j.jmoldx.2023.09.007. Epub 2023 Oct 7.
4
[The progress and challenge in the study of fusions and fusion families in hematological malignancies].[血液系统恶性肿瘤中融合基因及融合基因家族研究的进展与挑战]
Zhonghua Yi Xue Za Zhi. 2019 Nov 5;99(41):3216-3220. doi: 10.3760/cma.j.issn.0376-2491.2019.41.004.
5
CEL-Seq2-Single-Cell RNA Sequencing by Multiplexed Linear Amplification.通过多重线性扩增进行CEL-Seq2单细胞RNA测序
Methods Mol Biol. 2019;1979:45-56. doi: 10.1007/978-1-4939-9240-9_4.
6
PVT1: A long non-coding RNA recurrently involved in neoplasia-associated fusion transcripts.PVT1：一种长非编码 RNA，经常参与肿瘤相关融合转录本。
Gene. 2021 May 5;779:145497. doi: 10.1016/j.gene.2021.145497. Epub 2021 Feb 16.
7
InFusion: Advancing Discovery of Fusion Genes and Chimeric Transcripts from Deep RNA-Sequencing Data.InFusion：从深度RNA测序数据中推进融合基因和嵌合转录本的发现
PLoS One. 2016 Dec 1;11(12):e0167417. doi: 10.1371/journal.pone.0167417. eCollection 2016.
8
MLL-SEPTIN gene fusions in hematological malignancies.MLL-SEPTIN 基因融合在血液系统恶性肿瘤中的作用。
Biol Chem. 2011 Aug;392(8-9):713-24. doi: 10.1515/BC.2011.072. Epub 2011 Jun 30.
9
Clinical Evaluation of Massively Parallel RNA Sequencing for Detecting Recurrent Gene Fusions in Hematologic Malignancies.临床评价大规模平行 RNA 测序在血液系统恶性肿瘤中检测复发性基因融合的应用。
J Mol Diagn. 2019 Jan;21(1):163-170. doi: 10.1016/j.jmoldx.2018.09.002. Epub 2018 Oct 19.
10
RNA sequencing.RNA测序
Methods Mol Biol. 2011;759:125-32. doi: 10.1007/978-1-61779-173-4_8.

引用本文的文献

1
Masked by eosinophils: a cryptic presentation of pediatric B-ALL with IGH rearrangement.被嗜酸性粒细胞掩盖：伴有IGH重排的儿童B淋巴细胞白血病的隐匿表现
J Hematop. 2025 Jul 14;18(1):33. doi: 10.1007/s12308-025-00649-3.
2
Effective Utilization of a Customized Targeted Hybrid Capture RNA Sequencing in the Routine Molecular Categorization of Adolescent and Adult B-Lineage Acute Lymphoblastic Leukemia: A Real-World Experience.定制靶向杂交捕获RNA测序在青少年和成人B淋巴细胞系急性淋巴细胞白血病常规分子分类中的有效应用：一项真实世界经验
Mol Diagn Ther. 2025 May;29(3):407-418. doi: 10.1007/s40291-025-00779-5. Epub 2025 Apr 5.
3

本文引用的文献

1
Advances in B-cell Precursor Acute Lymphoblastic Leukemia Genomics.B 细胞前体急性淋巴细胞白血病基因组学的进展
Hemasphere. 2018 Jun 20;2(4):e53. doi: 10.1097/HS9.0000000000000053. eCollection 2018 Aug.
Bridging the Gap: Cost-Effective Strategies for Detecting Ph-Like B-Lineage ALL in Resource-Limited Settings.
缩小差距：在资源有限环境中检测Ph样B系急性淋巴细胞白血病的经济有效策略
Mol Diagn Ther. 2025 May;29(3):329-344. doi: 10.1007/s40291-025-00775-9. Epub 2025 Mar 28.
4
Acute Leukemia of Ambiguous Lineage: Diagnosis and Evaluation by Flow Cytometry.谱系不明确的急性白血病：流式细胞术诊断与评估
Cancers (Basel). 2025 Mar 3;17(5):871. doi: 10.3390/cancers17050871.
5
Molecular techniques in haematopathology: what and how?血液病理学中的分子技术：是什么以及如何应用？
Histopathology. 2025 Jan;86(1):38-57. doi: 10.1111/his.15332. Epub 2024 Oct 15.
6
'Evaluation of adverse prognostic gene alterations & MRD positivity in BCR::ABL1-like B-lineage acute lymphoblastic leukaemia patients, in a resource-constrained setting.在资源有限的环境中评估 BCR::ABL1 样 B 细胞系急性淋巴细胞白血病患者的不良预后基因改变和微小残留病灶阳性。
Br J Cancer. 2023 Jul;129(1):143-152. doi: 10.1038/s41416-023-02294-y. Epub 2023 May 8.
7
Myeloid Neoplasm with t(8;22)(p11;q11): A Mimicker of Chronic Myeloid Leukaemia in Blast Crisis.伴有t(8;22)(p11;q11)的髓系肿瘤：慢性髓系白血病急变期的模仿者
Indian J Hematol Blood Transfus. 2021 Apr;37(2):334-336. doi: 10.1007/s12288-020-01343-3. Epub 2020 Aug 31.
8
Clinical impact of panel-based error-corrected next generation sequencing versus flow cytometry to detect measurable residual disease (MRD) in acute myeloid leukemia (AML).基于panel 的纠错二代测序与流式细胞术检测急性髓系白血病（AML）微小残留病（MRD）的临床影响。
Leukemia. 2021 May;35(5):1392-1404. doi: 10.1038/s41375-021-01131-6. Epub 2021 Feb 8.